SweetValueLab
Write for us

Cigna Corporation — Wall Street Analyst Estimates & Price Targets

CI
NYSEHealthcareMedical - Healthcare PlansCIK 0001739940thecignagroup.comAbout CI
Last close · Oct 16, 2026302.30+3.49 (+1.17%)
Market cap$79.9B

6 firms' latest targets, last 90 days: median $340.50 ($307.00–$387.00), 13% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$250$300$350$400NovJan 2026MarMayJulSep2025-10-31 · Morgan Stanley: $3552025-10-31 · Barclays: $3002025-11-03 · Jefferies: $3102025-11-04 · Goldman Sachs: $3302025-11-05 · Wells Fargo: $3002025-11-12 · Bernstein: $2942025-11-12 · UBS: $2942025-12-02 · Guggenheim: $3182025-12-15 · TD Cowen: $3332026-01-05 · Truist: $3202026-01-05 · Barclays: $3052026-01-06 · Bernstein: $3072026-01-09 · Mizuho Securities: $3252026-02-06 · Barclays: $3032026-02-09 · Truist: $3382026-02-09 · UBS: $3752026-02-10 · Deutsche Bank: $3042026-02-17 · Truist: $3502026-04-20 · Jefferies: $3302026-05-01 · Raymond James: $3402026-05-01 · Baird: $3372026-05-01 · Mizuho Securities: $3302026-05-01 · Barclays: $3102026-05-05 · Bernstein: $3712026-05-20 · Morgan Stanley: $3612026-05-20 · Deutsche Bank: $3022026-05-22 · UBS: $4002026-05-26 · Barclays: $3042026-06-08 · Mizuho Securities: $3402026-06-16 · Wolfe Research: $3152026-07-08 · Bernstein: $3812026-07-31 · Baird: $3622026-07-31 · Guggenheim: $3612026-07-31 · Wells Fargo: $3072026-08-03 · Raymond James: $3202026-08-04 · Jefferies: $3072026-10-02 · Piper Sandler: $3872026-10-02 · Piper Sandler: $370
$250$300$350$400NovFebMayAug

Each firm's latest target

last 90 days · 6 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-02Piper Sandler$387.00$370.00▲ 5%+44%+28%
2026-08-04Jefferies$307.00$330.00▼ 7%+9%+2%
2026-08-03Raymond James$320.00$340.00▼ 6%+15%+6%
2026-07-31Baird$362.00$337.00▲ 7%+26%+20%
2026-07-31Guggenheim$361.00$318.00▲ 14%+25%+19%
2026-07-31Wells Fargo$307.00$300.00▲ 2%+7%+2%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2023reported$195.3B+8%$17.39-18%est. $193.1B+1%est. $24.8414
2024reported$247.1B+27%$12.12-30%est. $243.5B+1%est. $28.5113
2025reported$274.9B+11%$22.18+83%est. $272.3B+1%est. $29.6610
2026$287.2B+4%$30.51+3%$281.0B–$289.8B$30.45–$30.5813
2027$299.9B+4%$33.48+10%$292.9B–$308.5B$33.13–$33.8613
2028$316.0B+5%$37.14+11%$305.9B–$323.8B$31.25–$39.3516
2029$335.4B+6%$41.37+11%$326.2B–$342.6B$39.88–$42.5114
2030$347.6B+4%$46.63+13%$338.0B–$355.0B$44.95–$47.9214
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.